Pd03-04 a Phase 1b, First-in-human, Open-label, Single-arm Study Evaluating the Safety and Efficacy of Glx-100, a Novel Synthetic Glycosaminoglycan Replacement Therapy in Subjects With Interstitial Cystitis/bladder Pain Syndrome